Comparison of Outcomes of External Dacryocystorhinostomy and Transcanalicular Laser-Assisted Dacryocystorhinostomy in Patients with Primary Acquired Nasolacrimal Duct Obstruction


Mutlu D., Bayram N., ARICI M. K., Ozec A. V., ERDOĞAN H., TOKER M. İ.

KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, cilt.239, sa.6, ss.799-803, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 239 Sayı: 6
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1055/a-1720-1752
  • Dergi Adı: KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.799-803
  • Anahtar Kelimeler: anatomy, orbit, nasolacrimal ducts, ENDOSCOPIC DACRYOCYSTORHINOSTOMY, DIODE-LASER, ENDONASAL DACRYOCYSTORHINOSTOMY
  • Sivas Cumhuriyet Üniversitesi Adresli: Evet

Özet

Purpose This study aimed to compare anatomical and functional outcomes of external dacryocystorhinostomy (EX-DCR) and transcanalicular multidiode laser dacryocystorhinostomy (TDL-DCR) in patients with primary acquired nasolacrimal duct obstruction (PANDO). Methods This study was conducted on 60 eyes of 60 patients with PANDO. The study subjects were randomly divided into two groups. Group 1 included 30 patients who underwent EX-DCR, and group 2 included 30 patients who underwent TDL-DCR. Surgery success rates were determined by patency of the neo-ostium, with free saline flow on irrigation and the absence of epiphora. Results There were 23 women (76.7%) and 7 men (23.3%) with a mean age of 47.33 +/- 12.44 years in group 1, and 18 women (60%) and 12 men (40%) with a mean age of 46.2 +/- 19.4 years in group 2. There was no significant difference between groups 1 and 2 with respect to age or gender (p = 0.801, p = 0.267, respectively). The mean duration of symptoms was 3.2 years, ranging from 1.5 to 5 years. The mean postoperative follow-up was 12.3 +/- 2.44 months. At the end of the follow-up period, the surgery success rates were 96.7% (29/30 eyes) in group 1, and 90% (27/30 eyes) in group 2. There was no statistical difference in the surgery success rates between groups (p = 0.612). Conclusion TDL-DCR is a minimally invasive and safe procedure. The lack of bleeding and incision scar and shorter operation time suggest that TDL-DCR can be a good alternative in PANDO patients.